{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:57:28Z","timestamp":1648558648188},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00120-011-2775-4","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T10:06:33Z","timestamp":1329127593000},"page":"257-264","source":"Crossref","is-referenced-by-count":2,"title":["Instillationstherapie des nichtmuskelinvasiven Harnblasenkarzinoms"],"prefix":"10.1007","volume":"51","author":[{"given":"F.","family":"vom Dorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tschirdewahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"L\u00fcmmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,12]]},"reference":[{"key":"2775_CR1","first-page":"665","volume":"37","author":"RUTT","year":"1985","unstructured":"RUTT (Registry for Urinary Tract Tumors) (1985) Harnwegstumorregister, Jahresbericht. Verh Dtsch Ges Urol 37:665","journal-title":"Verh Dtsch Ges Urol"},{"key":"2775_CR2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00120-009-1990-8","volume":"48","author":"Tschirdewahn","year":"2009","unstructured":"Tschirdewahn S, Boergermann C, Becker M et al (2009) Urine-based cytological diagnosis against the background of the new histopathological classification. Urologe A 48(6):615\u2013618","journal-title":"Urologe A"},{"key":"2775_CR3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1464-4096.2001.02396.x","volume":"88","author":"Herr","year":"2001","unstructured":"Herr HW (2001) Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder? BJU Int 88(7):683\u2013685","journal-title":"BJU Int"},{"key":"2775_CR4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00120-010-2502-6","volume":"50","author":"Hess","year":"2011","unstructured":"Hess J, Tschirdewahn S, Szarvas T et al (2011) Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible? Urologe A 50(6):702\u2013705","journal-title":"Urologe A"},{"key":"2775_CR5","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","volume":"171","author":"Sylvester","year":"2004","unstructured":"Sylvester R, Osterlinck W, van der Meijden AP (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171(6 Pt 1):2186\u20132190","journal-title":"J Urol"},{"key":"2775_CR6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2008.01.015","volume":"53","author":"Sylvester","year":"2008","unstructured":"Sylvester R, Oosterlinck W, Witjes JA (2008) The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systemic review of published results of randomized clinical trials. Eur Urol 53(4):709\u2013719","journal-title":"Eur Urol"},{"key":"2775_CR7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-5347(01)67608-0","volume":"153","author":"Bouffioux","year":"1995","unstructured":"Bouffioux C, Kurth KH, Bono A et al (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma. Results of two European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short term versus long term treatment. J Urol 153(3 Pt 2):934\u2013941","journal-title":"J Urol"},{"key":"2775_CR8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000019581","volume":"33","author":"Okamura","year":"1998","unstructured":"Okamura K, Kinukawa T, Tsumura Y et al (1998) A randomized study of short-term versus long-term intravesical epirubicin instillation for superficial bladder cancer. Eur Urol 33(3):285\u2013288","journal-title":"Eur Urol"},{"key":"2775_CR9","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"Sylvester","year":"2002","unstructured":"Sylvester RJ, van der Meijden AP, Lamm DL (2002) Intravesicel bacillus calmette guerin reduces the risk of progression in patients with superficial bladder cancer: a metaanalyis of the published results of randomized clinical trials. J Urol 168(5):1964\u20131970","journal-title":"J Urol"},{"key":"2775_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","volume":"174","author":"Sylvester","year":"2005","unstructured":"Sylvester RJ, van der Meijden AP, Witjes JA, Kurth K (2005) Bacillus calmette guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174(1):86\u201391","journal-title":"J Urol"},{"key":"2775_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","volume":"56","author":"Malmstr\u00f6m","year":"2009","unstructured":"Malmstr\u00f6m PU, Sylvester RJ, Crawford DE et al (2009) An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Gu\u00e9rin for non-muscle-invasive bladder cancer. Eur Urol 56(2):247\u2013256","journal-title":"Eur Urol"},{"key":"2775_CR12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2010.11.038","volume":"59","author":"Oosterlinck","year":"2011","unstructured":"Oosterlinck W, Kirkali Z, Sylvetser R et al (2011) Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus calmette Guerin and with bacillus calmette Guerin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genitor-urinary group randomized phase 2 trial (30993). Eur Urol 59(3):438\u2013446","journal-title":"Eur Urol"},{"key":"2775_CR13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"Sylvester","year":"2010","unstructured":"Sylvester R, Brausi MA, Kirkels WJ et al (2010) Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus calmette Guerin, and bacillus calmette Guerin plus isoniazid in patients with intermediate- and high-risk stage TaT1 urothelial carcinoma of the bladder. Eur Urol 57(5):766\u2013773","journal-title":"Eur Urol"},{"key":"2775_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.juro.2008.03.038","volume":"180","author":"Cai","year":"2008","unstructured":"Cai T, Nesi G, Tinacci G et al (2008) Can early single dose instillation of epirubicin improve bacillus calmette Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study. J Urol 180(1):110\u2013115","journal-title":"J Urol"},{"key":"2775_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.eururo.2008.06.062","volume":"54","author":"Herr","year":"2008","unstructured":"Herr HW (2008) Is maintenance Bacillus Calmette-Gu\u00e9rin really necessary? Eur Urol 54(5):971\u2013973","journal-title":"Eur Urol"},{"key":"2775_CR16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.juro.2010.03.134","volume":"184","author":"Chade","year":"2010","unstructured":"Chade DC, Shariat SF, Adamy A et al (2010) Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol 184(2):464\u2013469","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-011-2775-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-011-2775-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-011-2775-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:48:18Z","timestamp":1558626498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-011-2775-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["2775"],"URL":"https:\/\/doi.org\/10.1007\/s00120-011-2775-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}